JNJ Stock Johnson & Johnson
STRONG BUY US · NYSEDiversified pharmaceuticals and medtech provide resilient compounding with defensive downside protection.
Future value: $279.41 (+4.92%) · 6-12 months · analyst consensus
Signal breakdown
- ▸Institutional-quality defensive earnings and healthcare sector positioning.
- ▸Above 50-day MA (+0.37%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (84.7% of range) — strength
Is JNJ a buy right now?
Trend: JNJ is trading above the 50-day average (+0.37%), RSI 57 — neutral momentum, with a 3-month return of -0.16%.
Valuation & quality: Johnson & Johnson trades on a trailing P/E of 40.4, forward P/E 22.9, PEG 2.94, price-to-book 7.86; fundamentals show net margin 16.2%, return on equity 20.0%, revenue growth 5.9% year on year.
Analyst consensus: 22 analysts have a mean 12-month price target of $279.41 (+4.9% vs the last close; range $190.00 – $320.00), consensus rating “buy”.
Income: trailing dividend yield 2.03%.
Our screen: STRONG BUY (score 4) — Diversified pharmaceuticals and medtech provide resilient compounding with defensive downside protection.
Computed from end-of-day data; not personal advice.
Our track record with JNJ
Our simulated $10,000 funds have traded JNJ 1 time — 1 of 1 closed trade profitable.
| Fund | Bought | Sold | Return |
|---|---|---|---|
| US Low-risk | 2026-06-22 @ $233.62 | 2026-09-23 @ $269.19 · AI review sell | +15.23% |
Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -1.60% | -6.00% | -2.00% | +12.70% | +0.90% | +3.70% | -0.40% | +0.60% |
Fundamentals
Analyst price target
Technical signals
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech.
Sector: Healthcare · Industry: Drug Manufacturers - General · United States · 138,200 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.